Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Allergy Diagnostics & Therapeutics Market Outlook

The global allergy diagnostics & therapeutics market was estimated at USD 41.19 billion in 2023 and is projected to increase further over the forecast period of 2024-2032 at a CAGR of 6.5%.

Rising incidences of allergic diseases, coupled with high demand for blood tests for in vitro diagnosis, are anticipated to drive the industry growth of the allergy diagnostics & therapeutics in the coming years.

Global Allergy Diagnostics and Therapeutics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Segmentation

The allergy diagnostics & therapeutics market can be divided on the basis of segments like product, allergen type, end-use, diagnostic tests, and drug class. The industry can be broadly categorised on the basis of product into:

Global Allergy Diagnostics and Therapeutics Market By Product

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

  • Instruments
  • Consumables
  • Services

The industry can be categorised on the basis of allergen type into:

  • Food
  • Inhaled
  • Drug
  • Others

The industry can be divided based on end-uses into:

  • Diagnostics labs
  • Hospitals
  • Academic Research Institutes

The industry can be divided on the basis of diagnostic tests as:

  • In-Vivo
  • Skin Prick Test
  • Intradermal
  • Patch Test
  • In-Vitro

The industry can be segmented based on drug class as:

  • Antihistamines
  • Decongestants
  • Corticosteroids
  • Mast Cell Stabilizers
  • Leukotriene Inhibitors
  • Nasal Anticholinergics
  • Immunomodulators
  • Autoinjectable Epinephrine
  • Immunotherapy

The EMR report looks into the regional markets of allergy diagnostics & therapeutics like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific regions.

Global Allergy Diagnostics and Therapeutics Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis

The growth of the allergy diagnostics & therapeutics industry is expected to be driven by a number of factors, such as the high incidence and high economic burden of allergic diseases, increased healthcare spending, and increased access to medical insurance in the United States. Within allergy testing, factors such as widespread availability and high consumption of assay kits are expected to drive the development of this segment in the following years. The category of inhaled allergens is projected to represent the largest share of the market for allergy diagnostics in the forecast period. Increasing environmental pollution is one of the main factors driving the market growth. Growing investments, rising research activities, and increasing acceptance from the United States for allergy treatment via medical insurance are the key factors accelerating the market growth.

Competitive Landscape

The report presents a detailed analysis of the following key players in the global allergy diagnostics & therapeutics market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • GlaxoSmithKline plc
  • Stallergenes Greer Ltd
  • Hitachi Chemical Co., Ltd
  • Omega Diagnostics Group PLC
  • bioMérieux SA
  • Thermo Fisher Scientific Inc.
  • Siemens Healthcare GmbH
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • Allergen Type
  • End Use
  • Diagnostic Tests
  • Drug Class
  • Region
Breakup by Product
  • Instruments
  • Consumables
  • Services
Breakup by Allergen Type
  • Food
  • Inhaled
  • Drug
  • Others
Breakup by End Use
  • Diagnostics labs
  • Hospitals
  • Academic Research Institutes
Breakup by Diagnostic Tests
  • In-Vivo
  • Skin Prick Test
  • Intradermal
  • Patch Test
  • In-Vitro
Breakup by Drug Class
  • Antihistamines
  • Decongestants
  • Corticosteroids
  • Mast Cell Stabilizers
  • Leukotriene Inhibitors
  • Nasal Anticholinergics
  • Immunomodulators
  • Autoinjectable Epinephrine
  • Immunotherapy
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • GlaxoSmithKline plc
  • Stallergenes Greer Ltd
  • Hitachi Chemical Co., Ltd
  • Omega Diagnostics Group PLC
  • bioMérieux SA
  • Thermo Fisher Scientific Inc.
  • Siemens Healthcare GmbH
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The global allergy diagnostics and therapeutics market attained a value of nearly USD 41.19 billion in 2023.

The market is projected to grow at a CAGR of 6.5% between 2024 and 2032.

The major drivers of the market include rising incidences of allergic diseases, coupled with high demand for blood tests for in vitro diagnosis, growing investments, and the rising research activities.

The increasing acceptance from the United States for allergy treatment via medical insurance are the key industry trends propelling the growth of the market.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The product type in the market includes instruments, consumables, and services.

Allergens can be divided into food, inhaled, and drug, among others. Inhaled allergen is the dominant type of allergy diagnostics and therapeutics in the industry.

End uses can be divided into diagnostics labs, hospitals, and academic research institutes.

In-vivo, skin prick test, intradermal, patch test, and in-vitro are the major diagnostic tests in this industry.

The major players in the industry are GlaxoSmithKline plc, Stallergenes Greer Ltd, Hitachi Chemical Co., Ltd, Omega Diagnostics Group PLC, bioMérieux SA, Thermo Fisher Scientific Inc., and Siemens Healthcare GmbH, among others.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63 287899028, +63 967 048 3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124